Zummo Jacqueline 4

What Happened

• Jacqueline Zummo, Chief Scientific Operations Officer of Protara Therapeutics (TARA), had 6,578 shares withheld by the company on Jan 20, 2026 to satisfy income tax obligations tied to the vesting of restricted stock units (RSUs). The shares were valued at $5.60 each, totaling $36,837. This is a tax-withholding disposition of vested RSUs rather than an open‑market sale.

Key Details

• Transaction date: 2026-01-20
• Price per share: $5.60; total value of shares withheld: $36,837
• Shares disposed/withheld: 6,578 (issuer withheld shares to cover taxes)
• Footnote: F1 — withholding relates to RSU awards granted Jan 19, 2023 and Jan 19, 2024
• Filing: Report filed 2026-01-22 (appears timely based on the Form 4 filing window)
• Shares owned after transaction: Not specified in the filing

Context

• This transaction is a routine tax withholding tied to RSU vesting (often handled via share surrender or net settlement) and is not necessarily a signal about the insider’s view of the company. It does not represent an active purchase or discretionary sale by the executive.